Form 8-K - Current report:
SEC Accession No. 0001104659-25-056875
Filing Date
2025-06-05
Accepted
2025-06-05 16:37:15
Documents
14
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517307d1_8k.htm   iXBRL 8-K 36033
2 EXHIBIT 99.1 tm2517307d1_ex99-1.htm EX-99.1 11780
6 GRAPHIC tm2517307d1_ex99-1img001.jpg GRAPHIC 3181
  Complete submission text file 0001104659-25-056875.txt   221733

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20250605.xsd EX-101.SCH 3023
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20250605_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20250605_pre.xml EX-101.PRE 22364
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2517307d1_8k_htm.xml XML 3558
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 251027664
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)